AS | Jotup

For Cloud Gaming and Video Hosting, Supermicro Offers MicroCloud, a High-Density 3U 8 Node System Utilizing AMD Ryzen Zen 4 7000 Series Processors

Retrieved on:

Tuesday, June 20, 2023

SAN JOSE, Calif., June 20, 2023 /PRNewswire/ -- Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for Cloud, AI/ML, Storage, and 5G/Edge, is introducing a new server that gives IT and data center owners a high performance and scalable solution to meet the needs for E-commerce, cloud gaming, code development, content creation, and virtual private servers. The new systems are designed to use AMD Ryzen™ 7000 Series processors optimized for server usage, based on the latest "Zen 4" core architecture, which has a max boost speed of up to 5.7 GHzi, including PCIe 5.0 support, DDR5-5200 MHz, and up to 16 cores (32 threads) per CPU. The new Supermicro MicroCloud is designed to use the latest system technology for a wide range of applications, including web hosting, cloud gaming, and virtual desktop applications.

Key Points:

The new Supermicro MicroCloud is designed to use the latest system technology for a wide range of applications, including web hosting, cloud gaming, and virtual desktop applications.
"We are expanding our application optimized server product lines to include the latest AMD Ryzen 7000 Series processors," said Michael McNerney, VP of Marketing and Security, Supermicro.
The Supermicro MicroCloud shares cooling and redundant power supplies across the eight blades for a more efficient and uninterrupted operation.
"The AMD Ryzen 7000 Series processors set a new standard for performance in a compact form factor for cloud and dedicated hosting environments."

Adjournment of Lone Star Bank Special Meeting of Shareholders Until July 11, 2023

Retrieved on:

Wednesday, June 7, 2023

Lone Star is announcing that the Special Meeting will be convened and immediately adjourned, without any business being conducted.

Key Points:

Lone Star is announcing that the Special Meeting will be convened and immediately adjourned, without any business being conducted.
The record date will remain April 19, 2023, and Lone Star shareholders of record as of the record date will continue to be entitled to vote at the Reconvened Special Meeting.
Lone Star shareholders of record on the record date may attend the Reconvened Special Meeting, including to vote and/or submit questions during the Reconvened Special Meeting.
Lone Star shareholders who have previously cast their votes do not need to vote again; however, Lone Star shareholders who have previously cast their votes but wish to change their votes may vote again by submitting another proxy card to Lone Star or by attending and voting at the Reconvened Special Meeting.

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock

Retrieved on:

Monday, June 5, 2023

ACT, Molecular biology, AS, Telesis, OR, Doctor of Philosophy, Securities and Exchange Commission (Philippines), Novalis, SELL, LAWS, SAN, Security (finance), Synthetic biology, Financial adviser

The warrants issued in the private placement will provide Telesis Bio with approximately $46.2 million in additional gross proceeds if they are cash exercised.

Key Points:

The warrants issued in the private placement will provide Telesis Bio with approximately $46.2 million in additional gross proceeds if they are cash exercised.
The Company also announced the appointment of Paul Meister, a partner at Novalis LifeSciences LLC, to the Company’s board of directors immediately following the closing.
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITY.
H.C. Wainwright & Co. acted as a financial advisor for the private placement.

Telesis Bio Secures Financing of $28.0 Million

Retrieved on:

Wednesday, May 31, 2023

ACT, Molecular biology, AS, Health, Telesis, OR, Fisher Scientific, Doctor of Philosophy, Novalis, SELL, Syneos Health, Thermo Fisher Scientific, LAWS, Security (finance), Synthetic biology, Automation, Management, Pharmaceutical industry

SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase agreement with a syndicate of healthcare-focused institutional investors that have agreed to provide initial upfront funding of $28.0 million in gross proceeds to Telesis Bio through a private placement of redeemable convertible preferred stock. The private placement also includes the issuance of warrants that, if cash exercised, would provide Telesis Bio with another $46.2 million in gross proceeds.

Key Points:

The private placement also includes the issuance of warrants that, if cash exercised, would provide Telesis Bio with another $46.2 million in gross proceeds.
“We are pleased to announce this financing led by Novalis LifeSciences LLC with strong support from existing investors,” shared Todd R. Nelson, CEO and Founder of Telesis Bio.
“We now anticipate full year revenue for the company to be approximately $35 million and operating expenses, including non-cash and one-time charges to be approximately $55 million.
Gross margin expectations of approximately 57% remain unchanged.”
The Company intends to use the proceeds from the financing for general corporate purposes.

FEMSA announces the pricing of the offering of shares of Heineken N.V. and Heineken Holding N.V.

Retrieved on:

Wednesday, May 31, 2023

MONTERREY, Mexico, May 31, 2023 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announces today the pricing of the sale by the Company and its wholly-owned subsidiaries Compañía Internacional de Bebidas, S.A. de C.V. and Grupo Industrial Emprex, S. de R.L. de C.V. of its entire holding of existing issued ordinary shares of both Heineken N.V. and Heineken Holding N.V. (together, the “Heineken Group”) by way of an accelerated book build of shares in the total amount of EUR 3.3 billion (approximately 6.0% of the combined interest in the Heineken Group) (the “Equity Offering”) as well as a bilateral sale of additional shares to Heineken N.V., except for any shares retained underlying FEMSA’s outstanding EUR 500 million 2.625% senior unsecured Exchangeable Bonds due 2026 (the “Bonds”), exchangeable into ordinary shares of Heineken Holding N.V. Given the strength of demand seen for the Equity Offering, the Company has decided not to proceed with the concurrent tap issuance of its outstanding Bonds announced on May 30, 2023.

Key Points:

The Equity Offering and the bilateral sale to Heineken N.V. have been approved by FEMSA’s board of directors and is conducted and announced in accordance with applicable law.
In addition to the Equity Offering, Heineken N.V. has committed to purchase 2.5 million shares in Heineken N.V. and 1.3 million shares in Heineken Holding N.V. or EUR 234.8 million and EUR 97.8 million respectively at the final offer prices, in aggregate equivalent to an additional c.10% of the Equity Offering.
Following the completion of the Equity Offering and the bilateral sale, FEMSA will not retain any residual holding in Heineken N.V. or in Heineken Holding N.V. except for any shares retained underlying FEMSA’s outstanding Bonds, exchangeable into ordinary shares of Heineken Holding N.V.
As previously indicated, L'Arche Green N.V., the entity through which the Heineken Family exercises control of Heineken Holding N.V., participated in the Equity Offering for an amount of c. EUR 50 million in shares in Heineken Holding N.V.
No prospectus or similar document will be published in connection with the Equity Offering.
BofA Securities, Goldman Sachs International, J.P. Morgan, Morgan Stanley and Citigroup are acting as joint bookrunners (the “Joint Bookrunners”) in respect of the Equity Offering.

FEMSA announces an approximately EUR 3.3 billion offering of shares of Heineken N.V. and Heineken Holding N.V. and a Concurrent Tap issuance of up to EUR 250 million of FEMSA’s existing Exchangeable Bonds due 2026 exchangeable into shares of Heineken Hold

Retrieved on:

Tuesday, May 30, 2023

MONTERREY, Mexico, May 30, 2023 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announces today an offering by the Company and its wholly-owned subsidiaries Compañía Internacional de Bebidas, S.A. de C.V. and Grupo Industrial Emprex, S. de R.L. de C.V. of existing issued ordinary shares of both Heineken N.V. and Heineken Holding N.V. (together, the “Heineken Group”) in the total amount of approximately EUR 3.3 billion (approximately 5.9% of the combined interest in the Heineken Group) (the “Equity Offering”). The Company also announces today a tap issuance of euro denominated senior unsecured bonds in the aggregate principal amount of up to EUR 250 million (the “New Bonds”), exchangeable into ordinary shares of Heineken Holding N.V. (the “Exchangeable Offering” and together with the Equity Offering, the “Offering”). The New Bonds will be consolidated and form a single series with the Company’s EUR 500 million 2.625% senior unsecured Exchangeable Bonds due 2026, originally issued on 24 February 2023 (the “Original Bonds” and together with the New Bonds, the “Bonds”) with effect from on or about 18 July 2023 (the “Consolidation Date”).

Key Points:

de C.V. of existing issued ordinary shares of both Heineken N.V. and Heineken Holding N.V. (together, the “Heineken Group”) in the total amount of approximately EUR 3.3 billion (approximately 5.9% of the combined interest in the Heineken Group) (the “Equity Offering”).
The Company also announces today a tap issuance of euro denominated senior unsecured bonds in the aggregate principal amount of up to EUR 250 million (the “New Bonds”), exchangeable into ordinary shares of Heineken Holding N.V. (the “Exchangeable Offering” and together with the Equity Offering, the “Offering”).
The Offering has been approved by FEMSA’s board of directors and is conducted and announced in accordance with applicable law.
Investors will have the opportunity to acquire shares in the Equity Offering in Heineken N.V. and Heineken Holding N.V.

Jonathan Milner calls Extraordinary General Meeting to restore focus to Abcam on governance, execution, and cost control

Retrieved on:

Tuesday, May 30, 2023

MAKE, ACT, AS, UPON, FOR, TAX, OF, NO, PAST, ITS, TIME, EACH, DATE, FINANCIAL, FUTURE, AND, IT, III, BY, NOT, UPDATE, ALL, THIS, SET, USE, FCA, EUROPEAN UNION, AWARE, EXPRESS, IS, ANY, FAIR, Medical device, Audit, EU

SUBJECT TO THE FOREGOING, AND AS SET FORTH BELOW, DR. MILNER INTENDS TO MAKE AVAILABLE AT AN APPROPRIATE TIME ADDITIONAL INFORMATION ABOUT THE EXTRAORDINARY GENERAL MEETING INCLUDING HOW TO VOTE AT SUCH MEETING.

Key Points:

SUBJECT TO THE FOREGOING, AND AS SET FORTH BELOW, DR. MILNER INTENDS TO MAKE AVAILABLE AT AN APPROPRIATE TIME ADDITIONAL INFORMATION ABOUT THE EXTRAORDINARY GENERAL MEETING INCLUDING HOW TO VOTE AT SUCH MEETING.
DR. MILNER HAS INVESTMENTS IN ABCAM PLC (THE “COMPANY”), AND CONSEQUENTLY HAS A FINANCIAL INTEREST IN THE PROFITABILITY OF HIS POSITIONS IN THE COMPANY.
DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Digicel announces successful completion of its consent solicitation in respect of Digicel Limited Notes

Retrieved on:

Monday, May 29, 2023

ACT, BY, AS, OR, Disclosure, SELL, SALE, Knowledge

Readers are cautioned not to place undue reliance on these materials and are referred to the Company's current public disclosure.

Key Points:

Readers are cautioned not to place undue reliance on these materials and are referred to the Company's current public disclosure.
This material may contain certain "forward-looking statements" and information relating to the Company and its affiliates that reflects the current views and/or expectations of the Company and its management with respect to future events.
Such statements are subject to a number of risks, uncertainties and assumptions.
ANY PUBLIC OFFERING OF SECURITIES IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS.

Inside information: Citycon Oyj announces the results of its tender offer for outstanding notes due 2024 of Citycon Treasury B.V.

Retrieved on:

Monday, May 29, 2023

ACT, ISLAND, AS, NOT, FOR, Interest, WAKE, SEE, EUR, ITS, ANY, ISIN, Cryptocurrency

HELSINKI, May 29, 2023 /PRNewswire/ -- On 22 May 2023, Citycon Oyj (the "Company") launched its invitation to holders of the EUR 457,617,000 2.50 per cent Guaranteed Notes due 2024 of Citycon Treasury B.V. guaranteed by the Company (ISIN: XS1114434167) issued in separate tranches on 1 October 2014 and 10 June 2020 (the "Securities"), to tender such Securities for purchase by the Company for cash (the "Offer"), on the terms and subject to the conditions set out in the tender offer memorandum dated 22 May 2023 (the "Tender Offer Memorandum") prepared by the Company. The Offer remains subject to the offer and distribution restrictions set out in the Tender Offer Memorandum. Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.The Company today announces that it will accept for purchase EUR 138,275,000 in aggregate principal amount of Securities validly tendered pursuant to the Offer. The total purchase consideration (including Accrued Interest Payments) for Securities validly tendered and accepted for purchase pursuant to the Offer will be EUR 137,110,080.32 (the "Total Purchase Consideration"), which will be funded by cash on the Company's balance sheet.The final results of the Offer are as follows:

Key Points:

PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT (SEE "OFFER AND DISTRIBUTION RESTRICTIONS" IN THE TENDER OFFER MEMORANDUM).
The Offer remains subject to the offer and distribution restrictions set out in the Tender Offer Memorandum.
Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.
The Company today announces that it will accept for purchase EUR 138,275,000 in aggregate principal amount of Securities validly tendered pursuant to the Offer.

Hammerhead Energy Inc. announces amendments to its substantial issuer bid

Retrieved on:

Friday, May 19, 2023

HEI, AS, Telephone number (mathematics), Tender offer, EDGAR, Schedule, Tender, SEDAR, Computershare, TSX, Letter, TIME, News, Security (finance), Variation, Circular, Warrant, Hammerhead

On May 19, 2023, Hammerhead filed with the United States Securities and Exchange Commission (the "SEC") Amendment No.

Key Points:

On May 19, 2023, Hammerhead filed with the United States Securities and Exchange Commission (the "SEC") Amendment No.
1 (the "Schedule TO-I/A") to the Tender Offer Statement on Schedule TO of Hammerhead reflecting certain amendments to the offer to purchase (the "Offer to Purchase") and accompanying issuer bid circular (the "Circular") of Hammerhead dated April 27, 2023.
The Schedule TO-I/A amends and supplements the Tender Offer Statement on Schedule TO filed by Hammerhead with the SEC on April 28, 2023 (the "Schedule TO").
Hammerhead announces that it is varying the terms of the Offer to reflect and incorporate the amendments to the Offer to Purchase and Circular set forth in the Schedule TO-I/A.